The message from new Genzyme CEO David Meeker: We’re back.In an exclusive Herald interview this week, the Vermont native who took over in October at the Cambridge-based biotech discussed new parent company Sanofi, the departure of longtime CEO Henri Termeer and the manufacturing problems that forever changed the company. “That was a devastating moment for Genzyme,” said Meeker, a pulmonary critical care specialist who joined Genzyme in 1994. “The inability to supply patients with the medication they need was something that affected us profoundly and, obviously, has and continues to be our number one focus going forward.”
